Global Specialty Pharmaceutical Partnering Report 2018: Terms and Agreements by Headline Value, Upfront Payments, Milestone Payments and Royalties 2012-2018 - ResearchAndMarkets.com
The "Global Specialty Pharmaceutical Partnering Terms and Agreements 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.
Global Specialty Pharmaceutical Partnering Terms and Agreements 2012 to 2018 report provides a detailed understanding and analysis of how and why companies enter Specialty Pharmaceutical partnering deals. This report provides details of the latest Specialty Pharmaceutical agreements announced in the life sciences since 2012.
The report takes the reader through a comprehensive review Specialty Pharmaceutical deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Specialty Pharmaceutical partnering deals.
The report presents financial deal term values for Specialty Pharmaceutical deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.
The middle section of the report explores the leading dealmakers in the Specialty Pharmaceutical partnering field; both the leading deal values and most active Specialty Pharmaceutical dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.
One of the key highlights of the report is that over 8,000 online deal records of actual Specialty Pharmaceutical deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.
- Specialty Pharmaceutical Partnering Terms and Agreements includes:
- Trends in Specialty Pharmaceutical dealmaking in the biopharma industry since 2012
- Analysis of Specialty Pharmaceutical deal structure
- Access to headline, upfront, milestone and royalty data
- Case studies of real-life Specialty Pharmaceutical deals
- Access to Specialty Pharmaceutical contract documents
- Leading Specialty Pharmaceutical deals by value since 2012
- Most active Specialty Pharmaceutical dealmakers since 2012
Available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific therapy target
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Trends in Specialty Pharmaceutical dealmaking
Chapter 3 Leading Specialty Pharmaceutical deals
Chapter 4 Most active Specialty Pharmaceutical dealmakers
Chapter 5 Specialty Pharmaceutical contracts dealmaking directory
Chapter 6 Specialty Pharmaceutical dealmaking by technology type
Chapter 7 Partnering resource center
For more information about this report visit https://www.researchandmarkets.com/research/rld8f6/global_specialty?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181029005360/en/